Literature DB >> 4415382

Pulmonary alveolar hypoxia: release of prostaglandins and other humoral mediators.

S I Said, T Yoshida, S Kitamura, C Vreim.   

Abstract

Hypoxic ventilation of isolated perfused cat lungs caused the frequent appearance in pulmonary perfusates of biologically active substances, which included prostaglandins or prostaglandin-like compounds. In anesthetized cats, inhibition of prostaglandin biosynthesis with infusions of aspirin (more than 50 milligrams per kilogram) reduced the pulmonary vasoconstrictor and bronchoconstrictor responses to hypoxic breathing.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4415382     DOI: 10.1126/science.185.4157.1181

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

1.  Meclofenamate does not reduce chronic hypoxic pulmonary vasoconstriction.

Authors:  S D Roos; E K Weir; J T Reeves
Journal:  Experientia       Date:  1976-02-15

2.  Pulmonary hypertention, blood coagulation and aspirin treatment in high altitude exposed cattle.

Authors:  F L Hays; W Bianca
Journal:  Int J Biometeorol       Date:  1976-03       Impact factor: 3.787

3.  Quantitative characteristics of the Feyrter cells and neuroepithelial bodies of the fetal rabbit lung in normoxia and short term chronic hypoxia.

Authors:  A Hernandez-Vasquez; J A Will; W B Quay
Journal:  Cell Tissue Res       Date:  1978-05-18       Impact factor: 5.249

4.  Quantitative characteristics of the Feyrter (APUD) cells of the neonatal rabbit lung in normoxia and chronic hypoxia.

Authors:  A Hernandez-Vasquez; J A Will; W B Quay
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

5.  The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

6.  Separate and combined use of verapamil, aspirin and captopril in experimental chronic pulmonary hypertension.

Authors:  D Kentera; D Susić; M Zdravković
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

7.  Relation of TXA2 and PGI2 to the difference in hypoxic pulmonary vasoconstriction between different strains of rats.

Authors:  Y C Su; X R Jin
Journal:  J Tongji Med Univ       Date:  1989

8.  Role of cytochrome P-450 in alveolar hypoxic pulmonary vasoconstriction in dogs.

Authors:  M A Miller; C A Hales
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.

Authors:  L J Rubin; J D Lazar
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  Differential effects of prostaglandins on canine intrapulmonary arteries and veins.

Authors:  B M Altura; N Chand
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.